Most medical device companies are aware that the FDA requires them to perform post-market activities to ensure the safety of their products. However, companies may not be aware that additional post-market activities not mandated by the FDA may be necessary to mitigate products liability exposures. This webinar will discuss the products liability consequences of failing to conduct certain post-market activities and elements of a post-market risk management strategy.

Eric Zalud, Esq. is a Partner and chair of the Litigation Practice Group at the law firm of Benesch Friedlander Coplan & Aronoff LLP. Mr. Zalud has litigated or arbitrated matters in 29 states, before state and federal, trial and appellate courts in various jurisdictions, and before the Surface Transportation Board, the United States Olympic Committee, and The United States Court of Veterans Appeals.

Mr. Zalud focuses his practice primarily upon commercial litigation, product liability matters, including medical device defense, consumer product and industrial product liability defense, product liability prevention matters, practice before the Consumer Product Safety Commission and the Federal Trade Commission regarding product issues, transportation and logistics, supply chain issues, and manufacturing law.